The hotly anticipated 8th Liquid Biopsy for Precision Oncology Summit returns as the only industry-led meeting uniting 250+ senior decision makers in the liquid biopsy field to enable patient access to precision oncology by overcoming sensitivity, biomarker selection, clinical validation, commercialization, reimbursement, and regulatory challenges to bring personalized medicine to patients faster.

Join Directors, Heads, and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine, Companion Diagnostics, and Experimental Medicine together with drug and diagnostic developers, regulatory experts, and payors for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.